Facebook tracking pixel
F19.90
ICD-10-CM
Polysubstance Use

Find information on polysubstance use, polysubstance dependence, and polysubstance abuse diagnosis, including clinical documentation requirements, medical coding guidelines (ICD-10 codes F19.20, F19.90, DSM-5 criteria), and treatment resources for healthcare professionals. Learn about substance use disorder, co-occurring disorders, dual diagnosis, and the impact of multiple substance use on patient care and recovery. Explore best practices for accurate diagnosis and effective treatment strategies for patients with polysubstance use involving alcohol, opioids, stimulants, or other substances.

Also known as

Multiple Substance Use
Polydrug Use

Diagnosis Snapshot

Key Facts
  • Definition : Using multiple substances simultaneously, like alcohol and opioids, leading to increased health risks.
  • Clinical Signs : Intoxication, withdrawal symptoms, organ damage, mental health issues, impaired judgment.
  • Common Settings : Detox centers, rehab facilities, outpatient clinics, support groups, primary care.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC F19.90 Coding
F19.-

Mental and behavioral disorders due to multiple drug use and use of other psychoactive substances

Covers disorders caused by combined use of multiple substances.

F10-F19

Mental and behavioral disorders due to psychoactive substance use

Includes various substance use disorders like alcohol, opioids, etc.

Z72.1

Problem related to lifestyle

Can be used to indicate a problem with polysubstance use as a lifestyle issue.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is there use of multiple substances?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Polysubstance use
Opioid Use Disorder
Stimulant Use Disorder

Documentation Best Practices

Documentation Checklist
  • Polysubstance use diagnosis requires specific substance documentation.
  • Document frequency, amount, and method of use for each substance.
  • Include details of impairment or distress caused by polysubstance use.
  • Specify how the substances contribute to the clinical picture.
  • Consider diagnostic criteria for substance use disorders (DSM-5, ICD-10).

Coding and Audit Risks

Common Risks
  • Unspecified Substances

    Coding F19.90 lacks specificity, impacting reimbursement and data analysis. CDI should clarify substances used for accurate coding.

  • Principal Diagnosis

    Incorrect sequencing of polysubstance use with other conditions can affect DRG assignment and payment. Thorough documentation is crucial.

  • Overlapping Codes

    Using multiple substance use codes when a combination code (F19.-) exists can lead to overcoding and compliance issues.

Mitigation Tips

Best Practices
  • Document all substances used: type, amount, frequency.
  • ICD-10-CM F19.2x: Specify each substance with Z79.891.
  • Query for substance use history, even if not primary.
  • CDI: Thorough documentation improves risk adjustment.
  • Compliance: Adhere to 42 CFR Part 2 confidentiality.

Clinical Decision Support

Checklist
  • 1. Documented recent use of >1 substance (ICD-10 F19.-)
  • 2. Assess impairment/distress (DSM-5 criteria)
  • 3. Rule out other medical/psychiatric causes
  • 4. Document specific substances used for billing accuracy
  • 5. Patient education on risks and treatment options

Reimbursement and Quality Metrics

Impact Summary
  • Polysubstance Use: Reimbursement and Quality Metrics Impact Summary
  • Keywords: Polysubstance use, SUD, ICD-10, F19, medical billing, coding accuracy, hospital reporting, reimbursement, quality metrics, value-based care, denial management
  • Impact 1: Lower reimbursement rates than single substance diagnoses. Accurate F19 coding crucial.
  • Impact 2: Impacts quality metrics related to SUD treatment outcomes, hospital readmissions.
  • Impact 3: Increased risk of claim denials with inaccurate coding. Proper documentation essential.
  • Impact 4: Affects value-based care performance due to complexity of care and resource utilization.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Document all substances
  • Specify use frequency
  • Code primary substance first
  • Check DSM-5 criteria
  • Consider F11.10 default

Documentation Templates

Patient presents with polysubstance dependence, exhibiting a problematic pattern of polysubstance use leading to clinically significant impairment or distress, as manifested by at least two of the following criteria within a 12-month period:  Impaired control over substance use (e.g., taking larger amounts or over a longer period than intended; persistent desire or unsuccessful efforts to cut down or control use; significant time spent obtaining, using, or recovering from substance use; craving).  Social impairment (e.g., failure to fulfill major role obligations at work, school, or home; continued substance use despite persistent or recurrent social or interpersonal problems caused or exacerbated by its effects; important social, occupational, or recreational activities given up or reduced because of substance use).  Risky use (e.g., recurrent substance use in situations in which it is physically hazardous; continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance).  Pharmacological criteria (e.g., tolerance, as defined by either a need for markedly increased amounts of the substance to achieve intoxication or desired effect, or markedly diminished effect with continued use of the same amount; withdrawal, as manifested by either the characteristic withdrawal syndrome for the substance, or the same or a closely related substance is taken to relieve or avoid withdrawal symptoms).  Substances involved include (list substances).  Differential diagnoses considered include substance-induced disorders, mood disorders, anxiety disorders, and personality disorders.  Treatment plan includes referral to addiction specialist for further evaluation and management, consideration for medication-assisted treatment, individual therapy focusing on cognitive behavioral therapy and motivational interviewing techniques, and support groups. Patient education provided on risks associated with polysubstance use, relapse prevention strategies, and available community resources.  Follow-up scheduled in (timeframe) to monitor progress and adjust treatment plan as needed.  Current mental status examination reveals (patient's mental status, including mood, affect, thought processes, and judgment).